Acute kidney damage is common and frequent in hospitalized patients, especially in critical patients, and is very fatal and associated with high mortality.

Until now, changes in blood urea nitrogen, serum creatinine, and
urine, which are not sensitive and specific, have been mainly used for the diagnosis of acute kidney damage.

• The GNL-MD-RFD001 developed by our company is an in vitro diagnostic kit made using a newly developed kidney disease marker. It can be used for clinical diagnosis in a non-invasive way by detecting kidney damage in patients early, and it is possible to detect kidney disease biomarkers with only a small amount of urine (2 μL).